NEW YORK, April 10, 2014 /PRNewswire/ --
Today, Analysts Review released its analysts' notes regarding
Anadarko Petroleum Corporation (NYSE: APC), Occidental Petroleum
Corporation (NYSE: OXY), Pioneer Natural Resources (NYSE: PXD),
Monsanto Company (NYSE: MON), and Freeport-McMoRan Copper &
Gold Inc. (NYSE: FCX). Private wealth members receive these notes
ahead of publication. To reserve complementary membership, limited
openings are available at:
http://www.AnalystsReview.com/register
--
Anadarko Petroleum Corporation Analyst Notes
On April 3, 2014, Anadarko
Petroleum Corporation (Anadarko) announced that the Company has
settled its long pending dispute with the Litigation Trust by
agreeing to pay $5.15 billion in
exchange for a complete release of all the claims against its
wholly owned subsidiary, Kerr-McGee Corporation. Even as the
Company expects this settlement to weigh on its Q1 2014 earnings,
the stock of Anadarko rallied as much as 15.67% in a single session
after the announcement. The settlement removes uncertainty over the
dispute that was weighing on Anadarko's stock since court ruling in
December 2013. Commenting on the
development, Anadarko Chairman, President and CEO Al Walker said, "This settlement agreement with
the Litigation Trust and the U.S. Government eliminates the
uncertainty this dispute has created, and the proceeds will fund
the remediation and cleanup of the legacy environmental liabilities
and tort claims." According to the terms of the agreement,
Litigation Trust and Kerr- McGee have mutually agreed to release
claims against each other. The full analyst notes on Anadarko
Petroleum Corporation are available to download free of charge
at:
http://www.AnalystsReview.com/04102014/APC/report.pdf
--
Occidental Petroleum Corporation Analyst Notes
On April 7, 2014, the stock of
Occidental Petroleum Corporation (Occidental) declined 1.02% to end
the day at $93.59, in line with
broader market indices which declined amid continued sell-off in
internet stocks and as investors parked their funds in defensive
stocks to protect against further declines. Shares in Occidental
opened the session at $94.72 and
oscillated in the range of $93.56 -
$94.81. The stock has a 52-week high of $99.42 and a 52-week low of $79.00. Over the past twelve months, the stock
has returned 15.37%, outperforming the Dow Jones Industrial Average
which returned 11.17% over the same period. The full analyst notes
on Occidental Petroleum Corporation are available to download free
of charge at:
http://www.AnalystsReview.com/04102014/OXY/report.pdf
--
Pioneer Natural Resources Analyst Notes
Pioneer Natural Resources (Pioneer) posted in its Events section
that the Company will host its Q1 2014 earnings conference call on
May 7, 2014 at 9:00 a.m. CT. According to Zacks Investment
Research data, the consensus EPS forecast for Q1 2014 is
$1.07. The Company reported Q4 2013
revenue and other income of $970.8
million, up 21.8% YoY, and a net loss of $1.4 billion. The Q4 2013 net loss of the Company
includes a loss of $507 million after
tax, related to discontinued operations and assets held for sale,
and an impairment charge of $957
million after tax. The full analyst notes on Pioneer Natural
Resources are available to download free of charge at:
http://www.AnalystsReview.com/04102014/PXD/report.pdf
--
Monsanto Company Analyst Notes
On April 2, 2014, Monsanto Company
(Monsanto) released its Q2 FY 2014 results (period ended
February 28, 2014). The Company
reported Q2 FY 2014 net sales of $5.8
billion, up 6.6% YoY, driven by a 4.1% YoY rise in corn
seeds and traits segment sales to $3.4
billion. During the quarter, the Company's net sales from
soybean and traits segment grew 21.1% YoY to $820 million and vegetables seeds segment grew
10.1% YoY to $219 million. The
Company's net income attributable to Monsanto came in at
$1.7 billion, or $3.15 per diluted share, compared to net income
of $1.5 billion, or $2.74 per diluted share, in Q2 FY 2013. Analysts
polled by Reuters had expected the Company's Q2 FY 2014 EPS to be
$3.06. For FY 2014, the Company
expects EPS in the range of $5.02 to
$5.22 per share. The full analyst notes on Monsanto Company
are available to download free of charge at:
http://www.AnalystsReview.com/04102014/MON/report.pdf
--
Freeport-McMoRan Copper & Gold Inc. Analyst
Notes
Freeport-McMoRan Copper & Gold Inc. (Freeport) posted on its Events section that
the Company will hold its Q1 2014 earnings conference call on
April 24, 2014 at 10:00 a.m. EDT. According to Zacks Investment
Research data, the consensus EPS forecast for Q1 2014 is
$0.55. During Q4 2013, the Company
reported revenues of $5.9 billion, up
30.4% YoY and diluted EPS of $0.68.
The full analyst notes on Freeport-McMoRan Copper & Gold Inc.
are available to download free of charge at:
http://www.AnalystsReview.com/04102014/FCX/report.pdf
--
About Analysts Review
We provide our members with a simple and reliable way to leverage
our economy of scale. Most investors do not have time to track all
publicly traded companies, much less perform an in-depth review and
analysis of the complexities contained in each situation. That's
where Analysts Review comes in. We provide a single unified
platform for investors' to hear about what matters. Situation
alerts, moving events, and upcoming opportunities.
--
=============
EDITOR NOTES:
- This is not company news. We are an independent source and our
views do not reflect the companies mentioned.
- Information in this release is fact checked and produced on a
best efforts basis and reviewed by Ananya
Ghosh, a CFA charterholder. However, we are only human and
are prone to make mistakes. If you notice any errors or omissions,
please notify us below.
- This information is submitted as a net-positive to companies
mentioned, to increase awareness for mentioned companies to our
subscriber base and the investing public.
- If you wish to have your company covered in more detail by our
team, or wish to learn more about our services, please contact us
at pubco [at] AnalystsReview.com.
- For any urgent concerns or inquiries, please contact us
at compliance [at] AnalystsReview.com.
- Are you a public company? Would you like to see similar
coverage on your company? Send us a full investors' package to
research [at] AnalystsReview.com for consideration.
COMPLIANCE PROCEDURE
Content is researched, written and reviewed on a best-effort
basis. This document, article or report is prepared and authored by
Analysts Review. An outsourced research services provider
represented by Ananya Ghosh, CFA,
has only reviewed the information provided by Analysts Review in
this article or report according to the Procedures outlined by
Analysts Review. Analysts Review is not entitled to veto or
interfere in the application of such procedures by the outsourced
provider to the articles, documents or reports, as the case may
be.
NOT FINANCIAL ADVICE
Analysts Review makes no warranty, expressed or implied, as to
the accuracy or completeness or fitness for a purpose (investment
or otherwise), of the information provided in this document. This
information is not to be construed as personal financial advice.
Readers are encouraged to consult their personal financial advisor
before making any decisions to buy, sell or hold any securities
mentioned herein.
NO WARRANTY OR LIABILITY ASSUMED
Analysts Review is not responsible for any error which may be
occasioned at the time of printing of this document or any error,
mistake or shortcoming. No liability is accepted by Analysts Review
whatsoever for any direct, indirect or consequential loss arising
from the use of this document. Analysts Review expressly disclaims
any fiduciary responsibility or liability for any consequences,
financial or otherwise arising from any reliance placed on the
information in this document. Analysts Review does not (1)
guarantee the accuracy, timeliness, completeness or correct
sequencing of the information, or (2) warrant any results from use
of the information. The included information is subject to change
without notice.
CFA® and Chartered Financial Analyst® are registered trademarks
owned by CFA Institute.
SOURCE Analysts Review